NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations.

Author: BaronB M, ChiE M, HarrisonB L, KehneJ H, McCloskeyT C, PalfreymanM G, WhittenJ P

Paper Details 
Original Abstract of the Article :
Pre-weaning rat pups emit ultrasonic vocalizations when removed from the litter. These 'separation-induced vocalizations' (SIV) are suppressed by classical benzodiazepine anxiolytics and by non-benzodiazepine anxiolytics which lack muscle relaxant and sedative properties. The present study used the ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/0014-2999(91)90141-c

データ提供:米国国立医学図書館(NLM)

NMDA Receptor Antagonists: A Potential Oasis in the Desert of Anxiety

Anxiety is a common human experience, often described as a feeling of unease or worry. This study explores the potential of NMDA receptor antagonists as a novel treatment for anxiety, using a rat model of separation-induced ultrasonic vocalizations (SIV). The researchers investigated the effects of various NMDA receptor antagonists on SIV and muscle relaxant properties.

NMDA Receptor Antagonists: A New Pathway for Anxiety Relief

The study found that NMDA receptor antagonists, including those acting at the glutamate recognition site and the ion channel, effectively suppressed SIV, suggesting potential anxiolytic properties. This is a promising finding, as it suggests that targeting the NMDA receptor complex may offer a new avenue for treating anxiety. Imagine a caravan crossing a treacherous desert, with each camel carrying a unique set of tools for navigating the difficult terrain. This research highlights the importance of exploring different pathways in the brain to alleviate anxiety.

A New Approach to Anxiety Treatment

The study's findings suggest that NMDA receptor antagonists may offer a novel approach to anxiety treatment, potentially avoiding the side effects associated with traditional benzodiazepine anxiolytics. This is a significant breakthrough, as it could provide much-needed relief for individuals struggling with anxiety disorders. This research paves the way for developing new and more effective treatments for anxiety, potentially easing the burden of this widespread and debilitating condition.

Dr.Camel's Conclusion

This research on NMDA receptor antagonists provides a glimpse into the complex workings of the brain and offers hope for new and more effective treatments for anxiety. It's like discovering a new oasis in the desert of anxiety, offering a refreshing change of pace and a potential path towards relief.

Date :
  1. Date Completed 1991-07-31
  2. Date Revised 2019-06-24
Further Info :

Pubmed ID

1675993

DOI: Digital Object Identifier

10.1016/0014-2999(91)90141-c

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.